Rainbow Childrens Medicare Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹548 Cr +23.1% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
RC

Rainbow Childrens Medicare Ltd

Q4 FY26Healthcare Services

Rainbow Childrens Medicare Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹460Cr
+24.3% YoY
+3.4% QoQ
Net profit
₹78Cr
+36.8% YoY
+5.4% QoQ
Margin
31%
0 pp YoY
−2 pp QoQ
Price₹1,433
Market cap₹16.2K Cr
P/E56.7

The short version

The company expects mature hospitals to operate at around 60% occupancy in the coming year, up from current 54%-56%, supporting growth targets. The company aims for an aspirational yet achievable growth rate of 20% in the current year (FY27) while maintaining margins.

From Rainbow Childrens Medicare Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company expects mature hospitals to operate at around 60% occupancy in the coming year, up from current 54%-56%, supporting growth targets.
  • Blended occupancy across the network is expected in the range of 56%-57%.
  • Revenue growth is anticipated around 20% for the upcoming financial year, driven by improved case mix, specialty services, and fertility business expansion.
  • Fertility segment is projected to grow at approximately 25% year-on-year for the next three years.
  • Expansion and ramp-up expected in key markets like Hyderabad, Bangalore, Chennai, and Andhra Pradesh.
  • Ongoing investments in digital marketing and technology aim to improve patient engagement and lead conversion, supporting volume growth.

2 more points from Rainbow Childrens Medicare Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Maintenance capex is approximately INR 45 crores per year across ~25 units.
  • Growth capex includes:
  • Around INR 400–500 crores expected for Gurugram projects over the next two years.
  • For other projects (Coimbatore, Pune, Indore, etc.), capex intensity is around INR 65–70 lakhs per bed.
  • Indore hospital planned for ~100 beds, capex included in pipeline.
  • Total development pipeline includes about 900 beds; excluding Gurugram, ~450 beds with capex aligned to bed numbers.
  • Gurugram projects:
  • Sector 56 (125 beds) targeted to commence operations in H2 FY28.
  • Sector 44 (325 beds) super specialty hub expected by Q1 FY29.
  • Pune regional greenfield hub hospital (150 beds) is in permission stage with excavation work ongoing.
  • Bangalore city will get a new 80-bed spoke hospital in a growing micro-market (Seegehalli).

2 more points from Rainbow Childrens Medicare Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Rainbow Children’s Medicare Limited has a development pipeline of approximately 900 beds in various stages of development and operationalization.
  • Investment required for new facilities in Coimbatore, Pune, Indore, and others is roughly INR 300–350 crores.
  • Additionally, approx INR 400–500 crores is expected to be invested in Gurugram projects over the next two years.

2 more points from Rainbow Childrens Medicare Ltd's call on order book

Create a free account to keep reading this call

Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Rainbow Childrens Medicare Ltd Q4 FY26 results — key figures

Rainbow Childrens Medicare Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue460370+24.3%445+3.4%
Operating profit (EBITDA)145115+26.1%147-1.4%
Operating margin31%31%0 pp33%-2 pp
Profit before tax8777+13%98-11.2%
Net profit (PAT)7857+36.8%74+5.4%
EPS (₹)7.595.55+36.8%7.14+6.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹548 Cr, net profit ₹84 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Suven Life Sciences (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Rainbow Childrens Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Rainbow Childrens Medicare Ltd Q4 FY26 results?

The company expects mature hospitals to operate at around 60% occupancy in the coming year, up from current 54%-56%, supporting growth targets. The company aims for an aspirational yet achievable growth rate of 20% in the current year (FY27) while maintaining margins.

What is Rainbow Childrens Medicare Ltd share price analysis?

Rainbow Childrens Medicare Ltd currently shows a neutral. The stock trades at a P/E of 56.7 with a market cap of ₹16,236 Cr. Investors should review the full earnings analysis for detailed insights.

Is Rainbow Childrens Medicare Ltd planning capital expenditure?

Maintenance capex is approximately INR 45 crores per year across ~25 units.

Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.